Rasonque sales drive up RevMed's stock; whistleblower sues Madrigal over MASH

Plus news about Rezera, ANI Pharmaceuticals, Cloudbreak Pharma and Anaheim Bio. RevMed’s stock jumps on early Rasonque sales: The RAS drug developer reported sales of its pancreatic cancer therapy Rasonque for the first time, netting ...